Neulapeg (Pegteograstim)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Neulapeg (Pegteograstim), covering 2024-04-09 to 2024-04-09. Get the full timeline:
Most recent: Clinical Trial Update: Prophylactic Administration of Neulapeg (Pegteograstim) in Patients With Locally Advanced or Metastatic Pancreatic Cancer Receiving the Modified FOLFIRINOX [Phase 2]